Regulatory PathRegulatory requirements compared

Active substance

Simeticone

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DEFLAT40 mg/mlDrops · Oral use1 Dropper ContainerSAR 10.25Generic · OTCHAYAT PHARMACEUTICAL INDUSTRIESValid
DEFLAT120 mgChewable tablet · Oral use24 BlisterSAR 10.25Generic · OTCHAYAT PHARMACEUTICAL INDUSTRIESValid
DEFLAT 40 MG/ML ORAL DROPS40 mg/mlDrops · Oral use1 Dropper ContainerSAR 13.65Generic · OTCHAYAT PHARMACEUTICAL INDUSTRIESValid
FLATICON 40MG CHEWABLE TABLETS40 mgChewable tablet · Oral use30 BlisterSAR 14.10Generic · OTCRIYADH PHARMAValid
FLATICON 60MG CHEWABLE TABLETS60 mgChewable tablet · Oral use30 BlisterSAR 15.40Generic · OTCRIYADH PHARMAValid
SALINAL 41.2MG-ML ORAL DROPS41.2 mg/mlOral drops, solution · Oral use1 Dropper ContainerSAR 7.35NCE · OTCGulf Pharmaceutical Industries (Julphar)Valid
SALINAL 42MG CHEWABLE TAB42 mgChewable tablet · Oral use30 BlisterSAR 10.65NCE · OTCGulf Pharmaceutical Industries (Julphar)Valid
Tumeeze Oral Emulsion40 mg/mlEmulsion · Oral use1 BottleSAR 6.85Generic · OTCAmman Pharmaceutical Industries (API)Valid
DISFLATYL DROPS 40MG-ML40 mg/mlDrops · Oral use1 Dropper ContainerSAR 14.65Generic · OTCMEDA PHARMA GmbH & Co KGWithdrawn by MAH · Not Marketed
DISFLATYL DROPS 40MG-ML40 mg/mlDrops · Oral use1 Dropper ContainerSAR 14.65Generic · OTCVALEANT PHARMACEUTICALSWithdrawn by MAH · Not Marketed
DISFLATYL TAB2, 40 mgChewable tablet · Oral use30 BlisterSAR 11.55NCE · OTCMEDA PHARMA GmbH & Co KGWithdrawn by MAH · Not Marketed
DISFLATYL TAB2, 40 mgChewable tablet · Oral use30 BlisterSAR 11.55NCE · OTCVALEANT PHARMACEUTICALSWithdrawn by MAH · Not Marketed
FLATIDYL 40MG CHEWABLE TAB40 mgChewable tablet · Oral use30 BlisterSAR 4.25Generic · OTCKAHIRA EYGEPTWithdrawn by regulatory authority · Not Marketed
PHAZYME TAB 60MG60 mgTablet · Oral use100 BlisterSAR 25.25NCE · OTCRED AND CARNIKInvalid · Not Marketed
PHAZYME TAB 60MG60 mgTablet · Oral use50 BlisterSAR 18.00NCE · OTCRED AND CARNIKInvalid · Not Marketed

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
GAS RELIEF TABLETS02328127125 MGTABLET (CHEWABLE) · ORALGUARDIAN DRUG COMPANY INC
GAS X ULTRA STRENGTH02300761180 MGCAPSULE · ORALHALEON CANADA ULC
GAS-X EXTRA STRENGTH00896675125 MGTABLET (CHEWABLE) · ORALHALEON CANADA ULC
OVOL DROPS0001361740 MG / MLDROPS · ORALCHURCH & DWIGHT CANADA CORP
OVOL FOR GAS 180 MG CAPSULE02239298180 MGCAPSULE · ORALCHURCH & DWIGHT CANADA CORP
OVOL FOR GAS 180 MG TABLET02247127180 MGTABLET · ORALCHURCH & DWIGHT CANADA CORP
OVOL FOR GAS 80 MG TABLET0029299080 MGTABLET · ORALCHURCH & DWIGHT CANADA CORP
PEDIACOL0224551040 MG / MLDROPS · ORALEURO-PHARM INTERNATIONAL CANADA INC
ULTRA STRENGTH GAS RELIEF02244204180 MGCAPSULE · ORALVITA HEALTH PRODUCTS INC
ULTRA STRENGTH PHAZYME 180MG SOFTGELS02237698180 MGCAPSULE · ORALC B FLEET COMPANY INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACSIMETHICONE 180 MG SOFTGEL$0.05412per EA23 Sep 2026
US NADACSIMETHICONE 80 MG TAB CHEW$0.0322per EA23 Sep 2026
NHS Drug TariffSimeticone 100mg capsules£3.9524 capsule1 Oct 2026
NHS Drug TariffSimeticone 40mg/ml oral suspension sugar free£4.6455 ml1 Oct 2026
NHS Drug TariffSimeticone 40mg/ml oral suspension sugar free£6.7885 ml1 Oct 2026
NHS Drug TariffSimeticone 42mg/5ml oral drops£2.19100 ml1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Safety signals and safety-related labeling changes

All safety entries for simeticone →

Combinations containing Simeticone

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.